Please assess the completion status of the following clinical trial:

Trial Title: A Remote Electronically Delivered Integrated Care Pathway: A Feasibility Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 13-18 years old at baseline~* Mood and Feelings Questionnaire - Childhood, long version (MFQ) score of ≥22~* Diagnosis of Major Depressive Disorder by impression from the referring psychiatrist and confirmed using the KSADS~* Internet access at home~* Access to a smartphone for personal and private use, with an associated standard data plan (ie. greater than or equal to 500 MB/month)~* Able to speak and read English fluently~Exclusion Criteria:~* Individuals that arecurrently receiving structured psychotherapy~* Clinically significant suicidal ideation that is defined as 'imminent intent' or attempted suicide in the past 6 months~* Co-morbid diagnosis of borderline personality disorder (as assessed by the Childhood Interview for Borderline Personality Disorder) (Zanarini, 2003), schizophrenia, bipolar disorder, moderate-to-severe eating disorder, obsessive compulsive disorder and/or severe alcohol/substance use disorder in the past 3 months~* Youth with known or clinically suspected intellectual disability or autism spectrum disorder~* Youth who are not able to provide informed consent for any other reason

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- Remote Electronically Delivered Integrated Care Pathway (ICP) (Type: EXPERIMENTAL): The remote electronically-delivered ICP (also known as eCARIBOU) will consist of psychiatry appointments through telemedicine every 4 weeks over 16 weeks, where the youth is at home. Prior to these appointments, measures (i.e., Mood and Feelings Questionnaire - MFQ) will be sent to the youth to be completed. Change in measure scores will be reviewed collaboratively between the psychiatrist and the youth to assist in making treatment decisions. The medication algorithm in the in-person ICP will be used to guide these decisions. The psychiatrist will also administer the Columbia Suicide Severity Rating Scale (C-SSRS) at each telepsychiatry appointment to monitor risk. Concurrently, youth will be offered internet-based Cognitive Behavioural Therapy (iCBT) and health-coaching via text.

Based on this trial design, predict the completion outcome and termination type (if applicable).